Anavex Life Sciences Corp (AVXL)

[Amatuer17]

Anything to counter this? Whose fault is it to create such situation? Not once but twice

“Following the announcement, the stock traded up over 30% despite criticism of the results from biotech journalist Adam Feuerstein, among others. The situation closely mirrors the announcement of the company's Rett syndrome results in early 2022, in which the company presented data with endpoints that were only changed in the clinical trial protocol weeks before, similarly bringing the criticism of the biotech press and others”